TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Nixonnoxin AB
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
5,211
|
3,422
|
4,049 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
4,173
|
2,152
|
3,721 |
| EBITDA |
3,753
|
1,795
|
3,718 |
| Total assets |
25,057
|
22,425
|
21,256 |
| Current assets |
14,621
|
15,662
|
14,527 |
| Current liabilities |
964
|
523
|
606 |
| Equity capital |
22,918
|
20,790
|
19,611 |
| - share capital |
32
|
34
|
33 |
| Employees (average) |
2
|
2
|
2 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
91.5%
|
92.7%
|
92.3% |
| Turnover per employee |
2,606
|
1,711
|
2,024 |
| Profit as a percentage of turnover |
80.1%
|
62.9%
|
91.9% |
| Return on assets (ROA) |
16.7%
|
9.6%
|
17.5% |
| Current ratio |
1516.7%
|
2994.6%
|
2397.2% |
| Return on equity (ROE) |
18.2%
|
10.4%
|
19.0% |
| Change turnover |
1,902
|
-649
|
696 |
| Change turnover % |
57%
|
-16%
|
21% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.